SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the three months ended March 31, 2025 and 2024:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Three Months Ended on March 31, 2025
Revenue	$	717,805		$	-		$	-		$	350,498		$	1,068,303
Cost of Sales		(602,785	)		-			-			(174,744	)		(777,529	)
Gross Profit		115,020			-			-			175,754			290,774
Operating Expenses		(1,144,805	)		(163,554	)		(512,932	)		(2,401,601	)		(4,222,892	)
Operating Loss		(1,029,785	)		(163,554	)		(512,932	)		(2,225,847	)		(3,932,118	)
Other Income (Expense)		10,720			(1,251,283	)		(698,374	)		(3,590,890	)		(5,529,826	)
Net Loss Before Income Tax		(1,019,065	)		(1,414,837	)		(1,211,306	)		(5,816,737	)		(9,461,944	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Three Months Ended on March 31, 2024
Revenue	$	5,752,994		$	-		$	535		$	332,678		$	6,086,207
Cost of Sales		(4,533,660	)		-			(2,041	)		(122,666	)		(4,658,367	)
Gross Profit (Loss)		1,219,334			-			(1,506	)		210,012			1,427,840
Operating Expenses		(361,696	)		(163,707	)		(826,961	)		(2,341,990	)	$	(3,694,354	)
Operating Income (Loss)		857,638			(163,707	)		(828,467	)		(2,131,977	)		(2,266,513	)
Other Income (Expense)		15,148			(3,491,466	)		(205,821	)		(1,365,140	)	$	(5,047,279	)
Net Income (Loss) Before Income Tax		872,786			(3,655,173	)		(1,034,288	)		(3,497,117	)		(7,313,792	)
March 31, 2025
Cash and Restricted Cash	$	4,776,950		$	355,797		$	4,216,873		$	16,974,644		$	26,324,263
Total Assets		43,617,855			1,993,681			5,599,876			39,253,333			90,464,745
December 31, 2024
Cash and Restricted Cash	$	4,928,236		$	326,540		$	3,375,824		$	19,553,127		$	28,183,726
Total Assets		44,683,563			3,176,729			5,446,468			43,382,430		$	96,761,977